Over the past twelve months ten Large-Cap stocks have underperformed all others. Here’s this week’s top 10 worst performing Large-Caps in the last twelve months:
| Name | 1 Year Price Returns (Daily) |
| Moderna (MRNA) | -81.68% |
| Enphase Energy (ENPH) | -67.73% |
| Albemarle (ALB) | -53.17% |
| Regeneron Pharmaceuticals (REGN) | -50.28% |
| AES (AES) | -48.00% |
| Dow (DOW) | -47.40% |
| Super Micro Computer (SMCI) | -45.72% |
| First Solar (FSLR) | -45.39% |
| Estee Lauder Companies (EL) | -44.88% |
| Teradyne (TER) | -43.10% |
Key Insights:
-
Cyclicals and rate-sensitive industries (utilities, materials, renewables) were hardest hit.
-
High-growth, high-multiple names have seen sharp reversals as cost of capital increased.
-
China exposure (Estee Lauder, Albemarle) was a common drag.
-
This group could be a reflection of macro headwinds more than company-specific disasters—offering potential opportunities for contrarian investors.
Here’s what they look like in one chart:
For all the latest news and podcasts, join our free newsletter here.
Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple:
